Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures
Sponsor: The University of Hong Kong
Summary
The aims of this vaccine trial are: (1) to measure humoral and selected cellular immune responses to repeated influenza vaccination with Flublok, including these responses' associations with age, birth year, and prior vaccination history; (2) to identify the characteristics of study participants who are vaccinated but still become infected with influenza virus ("vaccine failures") and participants who have poor immune responses to vaccination; and (3) to predict how influenza vaccinations and infections shape immunity.
Official title: The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE) Study - a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
977
Start Date
2020-10-05
Completion Date
2025-12-31
Last Updated
2026-05-15
Healthy Volunteers
Yes
Conditions
Interventions
FluBlok
Recombinant HA quadrivalent influenza vaccine (0.5mL Flublok®, Sanofi Pasteur) containing 180μg antigen, 45μg for each influenza strain included.
Placebo
0.5mL saline placebo.
Locations (1)
The University of Hong Kong
Hong Kong, Hong Kong